The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II – Therapy
- 1 May 2006
- journal article
- practice guideline
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 22 (7), 583-593
- https://doi.org/10.1016/s0828-282x(06)70280-x
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and NormoglycemiaArchives of Internal Medicine, 2005
- Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary PreventionStroke, 2005
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a β-blocker)International Journal of Cardiology, 2004
- Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or BothNew England Journal of Medicine, 2003
- Lifestyle Modification as a Means to Prevent and Treat High Blood PressureJournal of the American Society of Nephrology, 2003
- Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration ProjectThe American Journal of Cardiology, 2003
- Cardiovascular prevention and blood pressure reductionJournal Of Hypertension, 2003
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000